Published by Benjamin Chiou on 31st December 2024
(Sharecast News) - Autoimmune disease and cancer treatment developer Sareum has revealed that the commercial licence of its jointly developed SRA737 product has been terminated by a biopharma company in the US.
URL: http://www.digitallook.com/dl/news/story/34783590/...